Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance
Title: Colon Cancer Alliance - Letter to FDA_KM TA
Colon Cancer Alliance - Comment
This is comment on Rule
Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance
View Comment
Attachments:
Colon Cancer Alliance - Letter to FDA_KM TA
Title:
Colon Cancer Alliance - Letter to FDA_KM TA
Related Comments
View AllPublic Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0003
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0004
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0005
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0007
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0009
Feb 17,2012 11:59 PM ET